Ophthalmologic and intraocular non‐Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors
- 1 December 2004
- journal article
- review article
- Published by Wiley in Hematological Oncology
- Vol. 22 (4) , 143-158
- https://doi.org/10.1002/hon.741
Abstract
The aims of this study were to define the initial characteristics, natural history, and prognostic factors of patients with ophthalmologic and intraocular malignant lymphoma. All patients treated at the Institut Curie for lymphoma with ophthalmologic (orbit and/or adnexa) or intraocular involvement were retrospectively reviewed. A pathological review of all cases was performed according to the WHO classification. One hundred and forty‐five patients were selected for the study. Pathological review showed 36% MALT type lymphoma, 22% lymphoplasmocytic lymphoma, and 15% diffuse large B‐cell lymphoma. Ophthalmologic and ocular sites were intra‐orbital in 61 cases (42%) and conjunctival in 51 cases (35%), with bilateral involvement in 10% of cases. Stage IV was found in 32% of cases, with bone marrow involvement in 12%. With a median follow‐up of 90 months, the 5‐year DFS and OS were 64 and 79% for low‐grade NHL, and 43 and 50% for high‐grade NHL. On multivariate analysis, age greater than 59 years, elevated LDH level, stage IV, high‐grade histological subgroup, and presence of B‐symptoms had a negative impact on OS for the overall population. In conclusion, with a median follow‐up of 7.5 years, our large cohort of patients represents one of the largest published series on primary ophthalmologic and intraocular malignant lymphoma. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 36 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical OutcomeJournal of Clinical Oncology, 2003
- Clinical features associated with survival of patients with lymphoma of the ocular adnexaEye, 2003
- Clinicopathologic analysis of ocular adnexal lymphomas: Extranodal marginal zone b‐cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patientsAmerican Journal of Hematology, 2003
- Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueBlood, 2003
- The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemiaBlood, 2001
- Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survivalBritish Journal of Ophthalmology, 2000
- Intraocular-central nervous system lymphoma: Clinical features, diagnosis, and outcomesOphthalmology, 1999
- Lymphoproliferative lesions of the ocular adnexaOphthalmology, 1998
- Malignant tumors of the orbitOphthalmology, 1998